您好!博飞美科试剂欢迎您! 400-608-7598

5-溴-4-氯-3-吲哚半乳糖苷

X-GAL
博飞美科提供的所有产品仅用于科研等非医疗用途,非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料,可至下方“质量控制”中下载
PN05866
PERFEMIKER
7240-90-6
C14H15BrClNO6
408.63
品牌 货号 包装 纯度 目录价 会员价 库存 数量 购买车
PERFEMIKER PN05866-100mg 100mg >≥98% 待询 登录可见优惠价格
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
产品名称: 5-溴-4-氯-3-吲哚半乳糖苷
中文别名: 5-溴-4-氯-3-吲哚基-β-D-吡喃半乳糖苷;5-溴-4-氯-3-吲哚半乳糖苷;5-溴-4-氯-3-吲哚基-beta-D-吡喃半乳糖苷;5-溴-4- 氯-3-吲哚-β-D-半乳糖苷 X-GAL;5-溴-4氯-3-吲哚-β-D-半乳糖苷;5-溴-4氯-3吲哚基β-D 半乳糖;5-溴-4-氯-3-吲哚基β-D-半乳糖皮蒽[用于生化研究];5-溴-4-氯-3-吲哚-beta-D 半乳糖苷;5-溴-4-氯-3-吲哚-beta-d-半乳糖吡喃糖苷;5-溴-4-氯-3-吲哚-β-D-半乳糖苷;5-溴-4-氯-3-吲哚-β-D-半乳糖苷 (X-gal);5-溴-4氯-3-吲哚-β-D-半乳糖苷 X-gal;5-溴-4-氯-3-吲哚-β-D-吡喃半乳糖苷;5-溴-4-氯-3-吲哚半乳糖苷 X-Gal;5-溴-4-氯-3-吲哚半乳糖苷(x-gal);5-溴-4-氯-3-吲哚基 β-D-吡喃半乳糖苷;5-溴-4氯-3吲哚基beta-D半乳糖(X-GAL);5-溴-4-氯-3-吲哚基-beta-D-吡喃半乳糖苷 X-Gal;5-溴-4-氯-3吲哚基-D半乳糖苷;5-溴-4氯-3吲哚基β-D 半乳糖(X-gal);5-溴-4-氯-3-吲哚基-β-D-吡喃半乳糖苷X-GAL;X-gal 5-溴-4-氯-3-吲哚-β-D-半乳糖苷;5-Bromo-4-chloro-3-indolyl-beta-D-galactoside 别名:X-Gal;5-溴-4-氯-3-(β-D-吡喃半乳糖苷)吲哚;5-溴-4-氯-3-吲哚基-B-D-半乳糖甘(X-gal);5-溴-4氯-3-吲哚基-β-D-半乳糖苷;5-溴-4-氯-3-吲哚基β-D-半乳糖皮蒽;5-溴-4氯-3-吲哚-β-D-吡喃半乳糖苷X-GAL
英文名称: X-GAL
英文别名: 5-Bromo-4-chloro-3-(beta-D-galactopyranosyloxy)indole;X-gal;5-Bromo-4-chloro-3-indolyl β-D-galactopyranoside (X-gal);5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside;5-Bromo-4-chloro-3-indolyl beta-D-Galactopyranoside [for Biochemical Research];5-Bromo-4-chloro-1H-indol-3-yl β-D-galactopyranoside;5-Bromo-4-chloro-3-indolyl β-D-galactopyranoside;5-Bromo-4-chloro-3-indolyl-beta-D-galactoside;5-Bromo-4-chloro-3-indolyl-β-D-galactoside;BCIG;X-Gal​;5-bromo-4-chloro-3-indolyl beta-D-galactoside;5-Bromo-4-chloro-3-indolyl β-D-galactoside;5-Bromo-4-chloro-3-(β-D-galactopyranosyloxy)indole;5-Bromo-4-chloro-3-indolyl beta-galactoside;OPIFSICVWOWJMJ-AEOCFKNESA-N;V595OG374W;5-Bromo-4-chloroindol-3-yl-beta-D-galactopyranoside;5-Bromo-4-chloro-1H-indol-3-yl -D-galactopyranoside;X-Gal;5-Bromo-4-chloro-1H-indol-3-yl -D-galactoside-(1,5);5-Bromo-4-chloro-3-indolyl-beta-D-g;5-BROMO-4-CHLORO-3-C-INDOLYL-.BETA.-D-GALACTOPYRANOSE;s6820;AKOS015919187;5-bromo-4-chloro-3-indolyl b-d-galactopyranoside;MFCD00005666;A837518;BRD-K37294861-001-01-7;5-Bromo-4-chloro-3-indolyl beta-D-galactopyranoside, >=98%;HY-15934;B-7150;.beta.-D-Galactopyranoside, 5-bromo-4-chloro-1H-indol-3-yl;5-Bromo-4-chloro-3-indolyl beta-D-galactopyranoside, >=98%, powder;5-Bromo-4-chloro-3-indolyl beta -D-galactopyranoside;XGal;SR-01000631716-1;5-Bromo-4-chloro-3-indolyl beta-D-galactopyranoside, tablet;5-BROMO-4-CHLOROINDOL-3-YL, .BETA.-D-GALACTOPYRANOSIDE;UNII-V595OG374W;X-GAL [MI];AC-24654;C14H15BrClNO6;INDOLE, 5-BROMO-4-CHLORO-3-(.BETA.-D-GALACTOPYRANOSYLOXY)-;5-BROMO-4-CHLORO-3-INDOYL-.BETA.-GALACTOPYRANOSIDE;5-Bromo-4-chloro-3-indoxyl-beta-D-galactopyranoside;5-BROMO-4-CHLOROINDOL-3-YL .BETA.-D-GALACTOPYRANOSIDE;IDI1_031132;(2S,3R,4S,5R,6R)-2-[(5-bromo-4-chloro-1H-indol-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;HB4128;7240-90-6;5-bromo-4-chloroindol-3-yl beta-D-galactopyranoside;A-D-galactopyranoside;5-Bromo-4-chloro-3-indolyl-beta-D-galactoside;X-GAL;5-Bromo-4-chloro-1H-indoll-3-yl-?-D-galactopyranoside;(2S,3R,4S,5R,6R)-2-((5-Bromo-4-chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol;AMY41378;M02699;5-Bromo-4-chloro-3-indolyl beta-D-galactopyranoside;5-Bromo-4-chloro-3-indolyl-ss-D-Galactopyranoside;5-Bromo-4-chloro-3-indolyl-.beta.-D-galactoside;BCIGBCIG;Q238475;5-Bromo-4-chloro-3-indolyl beta-D-galactopyranoside, 98%;5-Bromo-4-chloro-3-indolyl beta-D-galactopyranoside, Vetec(TM) reagent grade, >=98%;CHEBI:75055;beta-D-Galactopyranoside, 5-bromo-4-chloro-1H-indol-3-yl;CHEMBL1242856;AS-11176;5-Bromo-4-chloro-1H-indol-3-yl hexopyranoside #;5-bromo-4-chloroindol-3-yl-;Maybridge4_000550;SCHEMBL98837;X-Gal, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside;5-BROMO-4-CHLORO-1H-INDOL-3-YL .BETA.-D-GALACTOPYRANOSIDE;CCG-41656;GALACTOPYRANOSIDE, 5-BROMO-4-CHLOROINDOL-3-YL, .BETA.-D-;EINECS 230-640-8;(2S,3R,4S,5R,6R)-2-[(5-bromo-4-chloro-1H-indol-3-yl)o...
品牌: PERFEMIKER
CAS号: 7240-90-6
分子式: C14H15BRCLNO6
分子量: 408.63
纯度: ≥98%
详细描述:

5-溴-4-氯-3-吲哚半乳糖苷

暂无相关技术资料
搜索质检报告(COA)